Castleview Partners’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,651
Closed -$69.9K 652
2022
Q2
$69.9K Buy
+1,651
New +$70K 0.06% 252
2022
Q1
Sell
-87,635
Closed -$1.65K 829
2021
Q4
$1.65K Buy
+87,635
New +$4.41M 0.01% 309
2021
Q2
$75K Buy
+1,651
New +$74.7K 0.03% 337

Other funds holding G

Castleview Partners's G Position: Q3 2022 in Review

Castleview Partners sold out of Genpact (G) in Q3 2022, closing a stake of 1,651 shares — an estimated $69.9K sold.

Castleview Partners first reported a position in G in Q2 2021 and held it in 3 quarters. The position peaked at $75K in Q2 2021. 335 funds tracked by Wall St. Rank hold G as of Q3 2022.

  • Castleview Partners reported no remaining Genpact position as of Q3 2022 after selling out during the quarter.
  • Castleview Partners sold 1,651 Genpact shares in Q3 2022, an estimated $69.9K.
  • Castleview Partners first reported a position in Genpact in Q2 2021 and held it in 3 quarters.
  • Castleview Partners's Genpact position peaked at $75K in Q2 2021.
  • 335 funds tracked by Wall St. Rank held Genpact as of Q3 2022.

Based on Castleview Partners's 13F filing for Q3 2022, filed 10 Nov 2022.